Latest news, updates, and announcements from Generate Biomedicines.
Generate Biomedicines, an AI-native biotech from Flagship Pioneering, has officially filed for a Nasdaq IPO under the symbol GENB. The company has raised 805 million dollars privately and recently dos...
